These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 719865)

  • 21. Determination of the quinidine analog, 7'-trifluoromethyldihydrocinchonidine-2HCl in plasma and urine by high-performance liquid chromatography.
    Pao J; de Silva JA
    J Chromatogr; 1980 Nov; 221(1):97-108. PubMed ID: 7451629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum quinidine determination: comparison of mass-spectrometric and extraction-fluorescence methods.
    Smith GH; Levy RH
    Drug Intell Clin Pharm; 1982 Sep; 16(9):693-5. PubMed ID: 7128461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of quinidine, dihydroquinidine, (3S)-3-hydroxyquinidine and quinidine N-oxide in plasma and urine by high-performance liquid chromatography.
    Nielsen F; Nielsen KK; Brøsen K
    J Chromatogr B Biomed Appl; 1994 Oct; 660(1):103-10. PubMed ID: 7858702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of quinine and quinidine in biological fluids by high performance liquid chromatography.
    Karbwang J; Na Bangchang K; Molunto P; Bunnag D
    Southeast Asian J Trop Med Public Health; 1989 Mar; 20(1):65-9. PubMed ID: 2772705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific high performance liquid chromatographic determination of quinidine in serum, blood, and urine.
    MacKichan JJ; Shields BJ
    Ther Drug Monit; 1987; 9(1):104-12. PubMed ID: 3576654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous liquid-chromatographic determination of three antiarrhythmic drugs: disopyramide, lidocaine, and quinidine.
    Flood JG; Bowers GN; McComb RB
    Clin Chem; 1980 Feb; 26(2):197-200. PubMed ID: 6986211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum quinidine concentrations: comparison of fluorescence, gas-chromatographic, and gas-chromatographic/mass-spectrometric methods.
    Huffman DH; Hignite CE
    Clin Chem; 1976 Jun; 22(6):810-2. PubMed ID: 1277466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An HPLC method for the quantitation of quinidine and its metabolites in plasma: an application to a quinidine-phenytoin drug interaction study.
    Pershing LK; Peat MA; Finkle BS
    J Anal Toxicol; 1982; 6(3):153-6. PubMed ID: 7109560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple fluorescence high-performance liquid chromatographic assay for dihydroquinidine in serum.
    Camsonne R; Moulin MA; Albessard F; Perault M
    Ther Drug Monit; 1984; 6(4):471-3. PubMed ID: 6515710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High performance liquid chromatographic method for the determination of sumatriptan with fluorescence detection in human plasma.
    Ge Z; Tessier E; Neirinck L; Zhu Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):299-303. PubMed ID: 15171943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific serum quinidine assay by high-performance liquid chromatography.
    Crouthamel WG; Kowarski B; Narang PK
    Clin Chem; 1977 Nov; 23(11):2030-3. PubMed ID: 912867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of quinidine by fluorescence polarization immunoassay and high pressure liquid chromatography.
    Bridges RR; Smith CM; Jennison TA
    J Anal Toxicol; 1984; 8(4):161-3. PubMed ID: 6381883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Micro-analysis for quinidine in serum by thin-layer chromatography followed by fluorescence densitometry.
    Kelner M; Bailey DN
    Clin Chem; 1983 Dec; 29(12):2100-2. PubMed ID: 6640909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-performance liquid chromatographic assay for labetalol in human plasma using a PRP-1 column and fluorometric detection.
    Alton KB; Leitz F; Bariletto S; Jaworsky L; Desrivieres D; Patrick J
    J Chromatogr; 1984 Nov; 311(2):319-28. PubMed ID: 6520179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The specificity of the extraction fluorescence assay for serum or plasma quinidine.
    Greenblatt DJ; Woo E
    J Clin Pharmacol; 1981; 21(8-9):333-6. PubMed ID: 7024328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-performance liquid chromatographic method for the quantitation of quinidine and selected quinidine metabolites.
    Hoyer GL; Clawson DC; Brookshier LA; Nolan PE; Marcus FI
    J Chromatogr; 1991 Dec; 572(1-2):159-69. PubMed ID: 1818051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved liquid-chromatographic assay of quinidine and its metabolites in biological fluids.
    Rakhit A; Kunitani M; Holford NH; Riegelman S
    Clin Chem; 1982 Jul; 28(7):1505-9. PubMed ID: 7083565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of liquid chromatography with fluorescence detection to liquid chromatography-mass spectrometry for the determination of fluoxetine and norfluoxetine in human plasma.
    Kovacevic I; Pokrajac M; Miljkovic B; Jovanovic D; Prostran M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):372-6. PubMed ID: 16356789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid-chromatographic determination of antidysrhythmic drugs: procainamide, lidocaine, quinidine, disopyramide, and propranolol.
    Kabra PM; Chen SH; Marton LJ
    Ther Drug Monit; 1981; 3(1):91-101. PubMed ID: 7233493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of quinidine analogs using ion-pairing HPLC.
    Al-Kaysi HN; Small LD; Murray WJ; Haddadin M
    J Chromatogr Sci; 1984 Feb; 22(2):80-3. PubMed ID: 6699121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.